Responsible for:- shaping GPD’s Data, Digital & Technology (DD&T) strategy for the Global Portfolio Division aligned to Takeda’s business imperative, - establishing and communicating a vision and narrative to drive digital transformation across the global division, - guiding how we implementation of our operating model, oversee DD&T investment areas, - as well as drive organizational change management and value demonstration to the broader organization.

Digital Health Product StrategyDigital Biomarkers, Digital MedicineIntegrated CareCoordinated CareOutcome Based Business ModelArtificial IntelligenceSoftware as Medical Device SAMD

Corporate and FranchiseStrategy, Business Planning,Post Merger Integration,Business Operations, Performance Management

Translating Corporate and Brand Strategy into Customer Strategy and Digital Strategy.Worked closely with Franchises Heads, Integrated Brand Teams (IBTs) and Markets GMs, and led several Strategic Programs/Projects including: - Customer Excellence,- Customer Experience Strategy, - Digital Engagement (MCM) and Digital Ecosystem Roadmap,- Congress Experience Optimization,- Value-Based Key Account Management (VB-KAM) and Partnerships with Healthcare Providers,- KAM Orchestrator Model,- Customer Solutions including Digital Health services (Human Centered Design), Patient Pathway Optimization (LEAN) and Coordination of Care, Outcomes measurement, Value-Based Contracting Models and PROs,- Customer Excellence Capabilities Development.Set up Business Partnership model with key Franchises (IBD, Hematology and Oncology) and Markets. Set up CX Community and CX Knowledge Management and Collaboration Hub.

Driving Corporate EUCAN Strategy, Digital Transformation, Digital Health Solutions and Innovative Go-to-Market Models to better serve patients and fit in the future healthcare landscape. Led Strategic Programs/Projects: - EUCAN Corporate Strategy Refresh, - Customer Engagement of the Future (Digital Engagement across the Customer Journeys), - Digital Health Strategy (including portfolio of disruptive ideas),- Integrated Care Solution solutions (AI / ML Based Personalized Patient Care allowing Coordination of Care between HCPs and Patients, Digital Markers and PROs).Key Franchises: Immuno therapy IBD, Neuroscience and Hemato-Oncology

Health Tech Without Borders is an independent, global non-profit movement providing digital health and telehealth aid where it’s needed most. Health Tech without Borders is not affiliated with Doctors Without Borders, which is a registered trademark of Bureau International de Medecins Sans Frontieres.

Not-for-Profit Learning and Collaboration Community

Focused on Lifesciences and Consumer Goods. Acted as Industry Expert in Digital Strategy and Transformation, Business Model Innovation as well as Commercial Excellence and Innovation with a wide array of high-profile life sciences and consumer product clients (Novartis, MSD, Bayer, Merck, Abbott, Abbvie, Roche, JnJ, Pfizer, Fresenius, Novo Nordisk, Nestle, Mondelez).Co-developed numerous service offerings and solutions: Digital Transformation, Customer Experience Engineering, Next Gen Patient Support Programs, and Business Model Innovation in Digital Health. Continually built and maintained new client relationships; consequently creating and implementing innovative value propositions which grew client business.During last 7 years at EY, led and delivered numerous high profile projects with top 10 Pharma players (non-exhaustive):- Customer Experience Strategy in CVMD, Specialty Care- Commercial Engagement Model (Cross-Channel Strategy) in Oncology- Digital Health Strategy and Business Model - Digital Strategy and Operations- Business Models Development - "Beyond the Pill" Strategy- Next Gen Patient Support Program - Digital Health- Health Services Strategy and Business Models Development (New revenue streams identification)- Healthcare System Strengthening Initiatives within Corporate Strategy - Digital Communications Operating & Governance Model- EU Digital Transformation and Entrepreneurship (European Commission)- Social Media Analytics and Customer Insights- Point of Sales Analytics – Customer and Patient Insights Development- IFPMA CEO Leadership and presidency strategy- Africa Health Institute Initiative (secondment with Novartis)

Worked closely with top 10 pharmaceutical organizations across Europe in creating feasibility studies and business cases to pioneer and implement new business strategy and operational excellence. Led several projects in business transformation: Share Service center Design and Implementation (Finance, Procurement, and HR), Operational Excellence (Lean, Six Sigma), Finance and Supply Chain Transformation.

Oversaw a 12-person multidisciplinary and multicultural team. Led and executed the strategic planning process. Efficiently grew and coordinated several high-level licensing and co-development programs from startup and negotiations to successful execution. Launched several in-lincence and generic products in Oncology, Cardiovascular and HIV in Middle East and Africa.- Portfolio Management- Business Development and In-licensing- Product Development - Product planning and launch (CVMD, Respiratory, Oncology, HIV)- Regulatory Affairs and Dossier Development- Launch Readiness and Planning